Integrated PV and MI: Where Medical Information Meets Safety Excellence
Connecting Medical Insight with Safety Excellence
At APCER, Medical Information and Pharmacovigilance work as one connected system. By aligning medical inquiry management with pharmacovigilance activities, we ensure that safety information flows smoothly between teams. This integrated approach strengthens the accuracy of adverse event reporting, reduces compliance risk, improves response timelines, and delivers medically sound outcomes that stand up to regulatory scrutiny across every market.
Our teams are made up entirely of healthcare professionals, supported by advanced technology platforms and global operations that run around the clock throughout the year. With deep experience across complex regulatory environments and diverse product portfolios, APCER helps organizations respond to medical inquiries quickly, maintain regulatory confidence, and focus their energy on innovation while we help safeguard patient safety and reputation.
Why Leading Life Sciences Companies Choose APCER
Delivering trusted safety and medical information services requires clinical expertise, operational discipline, and a deep understanding of global regulatory expectations. APCER brings together experienced healthcare professionals, strong quality systems, and scalable global operations to help organizations respond with confidence while protecting patient safety and regulatory integrity.
Our Impact at a Glance
PV-MI integration boosts case processing efficiency
A US-based innovator leveraged a comprehensive, integrated PV and MI services.
Quality and Compliance
- Version-controlled SOPs
- Role-based structured training
- End-to-end Deviation and CAPA lifecycle management
- Risk-based audit program
- electronic Quality Management System (eQMS) and electronic Learning Management System (eLMS)
Ready for a partner who matches your ambition?
With APCER, you gain more than a service provider—you secure a champion for compliance, a catalyst for growth, and a steadfast ally dedicated to protecting patients and your reputation.
Real Results. Real Trust.
Real Stories
Sincerely thank you for all the effort, thoroughness and professionalism that went through conducting and reporting on this FDA PADER Gap Analysis as we now embark on our journey towards documentation and process improvement to ensure readiness for an actual inspection.
Director, Drug Safety and Medical Information
Canada-based global pharma
The APCER Pharmacovigilance team demonstrated exceptional collaboration and inspection readiness during FDA PADE Inspection. The accuracy, consistency, and completeness of expedited reports, reconciliations, and aggregate safety documentation clearly reflected strong teamwork and compliance across all deliverables.
VP, Regulatory and Quality
US-based biopharma
With all the transformation and rapid growth happening, having a reliable PV/med info partner like the APCER group has truly been invaluable—it’s made a real difference in helping us navigate the complexities and keep challenges to a minimum.
VP, Medical Affairs
US-based specialty pharma
... the preparation and support for our BPD Type 2a meeting were a strong example of APCER’s commitment and effectiveness and instrumental in keeping us aligned and confident in our regulatory strategy. We have greatly valued the team’s responsiveness, collaborative approach, and sound regulatory judgment.
Chief Medical Officer
A clinical-stage biopharma
Phase 1 completion is an achievement that demonstrates APCER's scalability, flexibility, and operational readiness. It reflects exceptional cross-functional collaboration.
Associate Director, IT Business Partner
Japan-headquartered, global healthcare company
I want to sincerely appreciate all the great work Team APCER has been doing. Their strong attention to detail, agility in handling tasks, and consistent respect for timelines have been truly impressive.
Associate Director, Safety Physician
Japan-headquartered, global healthcare company
Deep gratitude to entire APCER team for their efforts in working hard to complete the cases. While the system outage was well beyond their control, their strong work to make up for the lost time ensured that we're able to maintain compliance.
Associate Director, Pharmacovigilance Operations
US-based biotech
Sincere appreciation for APCER's partnership and dedicated service. The team’s commitment, adaptability, and collaborative approach have been instrumental in supporting our pharmacovigilance operations through both high and low volumes of activity.
Sr.Director, PV Operations-Global Case Management
US-based biotech
I’ve greatly valued APCER’s commitment to excellence. Their contributions have played a key role in helping us uphold our compliance standards and achieve strong performance across key metrics, including timely deviation closure, audit readiness, and quality of deliverables.
Sr. Director PV Ops – Pharmacovigilance Center of Excellence
US-based biotech
